Correlation Between Abivax SA and Carmat
Can any of the company-specific risk be diversified away by investing in both Abivax SA and Carmat at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abivax SA and Carmat into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abivax SA and Carmat, you can compare the effects of market volatilities on Abivax SA and Carmat and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abivax SA with a short position of Carmat. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abivax SA and Carmat.
Diversification Opportunities for Abivax SA and Carmat
Very poor diversification
The 3 months correlation between Abivax and Carmat is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Abivax SA and Carmat in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmat and Abivax SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abivax SA are associated (or correlated) with Carmat. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmat has no effect on the direction of Abivax SA i.e., Abivax SA and Carmat go up and down completely randomly.
Pair Corralation between Abivax SA and Carmat
Assuming the 90 days trading horizon Abivax SA is expected to generate 0.6 times more return on investment than Carmat. However, Abivax SA is 1.66 times less risky than Carmat. It trades about 0.02 of its potential returns per unit of risk. Carmat is currently generating about -0.06 per unit of risk. If you would invest 619.00 in Abivax SA on September 24, 2024 and sell it today you would earn a total of 87.00 from holding Abivax SA or generate 14.05% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Abivax SA vs. Carmat
Performance |
Timeline |
Abivax SA |
Carmat |
Abivax SA and Carmat Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Abivax SA and Carmat
The main advantage of trading using opposite Abivax SA and Carmat positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abivax SA position performs unexpectedly, Carmat can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmat will offset losses from the drop in Carmat's long position.Abivax SA vs. Kalray SA | Abivax SA vs. Biosynex | Abivax SA vs. Eurobio Scientific SA | Abivax SA vs. OSE Pharma SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |